Sign in →

Test ID FLYSO Lysozyme, Serum

Method Name

Quantitative Enzyme-Linked Immunosorbent Assay

Reporting Name

Lysozyme, Serum

Specimen Type

Serum

Draw blood in a serum gel tube(s). (Plain red-top tube is acceptable). Spin down and send 1 mL serum refrigerate in a plastic vial.

Specimen Minimum Volume

0.4 mL

Specimen Stability Information

Specimen Type Temperature Time
Serum Refrigerated (preferred) 7 days
  Frozen  90 days

Clinical Information

Serum lysozyme levels may be elevated in acute myelomonocytic leukemia (FAB-M4), chronic myelomonocytic leukemia (CMML), and chronic myelocytic leukemia (CML). Increased serum lysozyme activity is present in tuberculosis, sarcoidosis, megaloblastic anemias, acute bacterial infections, ulcerative colitis, regional enteritis, and Crohn disease. Elevated serum lysozyme occurs during severe renal insufficiency, renal transplant rejection, urinary tract infections, pyelonephritis, glomerulonephritis, and nephrosis.

Reference Values

0.00 - 2.75 ug/mL

 

Day(s) Performed

Sunday, Tuesday, Thursday

Report Available

1 - 5 days

Performing Laboratory

ARUP Laboratories

Test Classification

This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

CPT Code Information

85549

NY State Approved

Yes